MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: Life Sciences, Medical Devices & Health Information Technology
2025: Top 10 U.S. Biopharma Clusters 2025
Massachusetts
*Industry: Massachusetts
TransCode Therapeutics, Inc. (NASDAQ: RNAZ)*
Organization & Developments: TransCode Therapeutics
Parents
TransCode Therapeutics, Inc. (NASDAQ: RNAZ)*
Children
Founded to develop RNA-based treatment modalities to treat metastatic cancer, 'which causes approximately 90% of all cancer deaths representing over nine million deaths per year worldwide.'
The firm's lead candidate, TTX-MC138, is being developed to combine 'proprietary iron-oxide nanoparticles and oligonucleotides that specifically target microRNA-10b
Jumps
Finance & Acquisitions: TransCode Therapeutics
Key People: TransCode Therapeutics